These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10460401)

  • 1. Quality-of-life aspects in urology - benign prostatic hyperplasia.
    MacDonagh R; Pearcy R
    World J Urol; 1999 Aug; 17(4):199-204. PubMed ID: 10460401
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of benign prostate hyperplasia].
    Romics I
    Orv Hetil; 2010 Mar; 151(12):506-8. PubMed ID: 20231135
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing benign prostatic hyperplasia.
    Garnett S; Abrams P
    Practitioner; 2001 Oct; 245(1627):830-2, 834, 836 passim. PubMed ID: 11677898
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of benign prostatic hyperplasia: surgery, medical therapy, or watchful waiting.
    Sall M; Bruskewitz RC
    Compr Ther; 1996 Sep; 22(9):554-8. PubMed ID: 8902346
    [No Abstract]   [Full Text] [Related]  

  • 5. [New therapeutic trends in benign hypertrophy of the prostate].
    Chatelain C
    Chirurgie; 1999 Jun; 124(3):223-31. PubMed ID: 10429295
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of benign prostatic hypertrophy].
    Romics I
    Orv Hetil; 2003 Nov; 144(45):2229-30. PubMed ID: 14686009
    [No Abstract]   [Full Text] [Related]  

  • 7. Benign prostatic hyperplasia. Medical and minimally invasive treatment options.
    Oesterling JE
    N Engl J Med; 1995 Jan; 332(2):99-109. PubMed ID: 7527494
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of the patient with benign prostatic hyperplasia.
    Carlin BI; Resnick ML
    Compr Ther; 1996 Sep; 22(9):586-91. PubMed ID: 8902350
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia.
    Lowe FC; McDaniel RL; Chmiel JJ; Hillman AL
    Urology; 1995 Oct; 46(4):477-83. PubMed ID: 7571214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 73-year-old man with symptomatic benign prostatic hyperplasia.
    Barry MJ
    JAMA; 1997 Dec 24-31; 278(24):2178-84. PubMed ID: 9417013
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of different therapies on symptoms of benign prostatic hyperplasia: a prospective study.
    Kawachi I; Barry MJ; Giovannucci E; Rimm EB; Colditz GA; Stampfer MJ; Willett WC
    Clin Ther; 1996; 18(6):1118-27. PubMed ID: 9001828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign prostatic hyperplasia. New concepts in the 1990s.
    Moul JW
    Postgrad Med; 1993 Nov; 94(6):141-6, 151-2. PubMed ID: 7694269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate disease in older men: 1. Benign hyperplasia.
    Albertsen PC
    Hosp Pract (1995); 1997 May; 32(5):61-4, 67-8, 77 passim. PubMed ID: 9153140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
    Pushkar' DIu; Kosko DV; Loran OB; Kan IaD; Sapozhnikov IM; Tevlin KP
    Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of benign prostatic hyperplasia.
    Walsh PC
    N Engl J Med; 1996 Aug; 335(8):586-7. PubMed ID: 8678937
    [No Abstract]   [Full Text] [Related]  

  • 16. Finasteride and doxazosin alone or in combination for the treatment of benign prostatic hyperplasia.
    Bhardwa J; Goldstraw M; Tzortzis S; Kirby R
    Expert Opin Pharmacother; 2007 Jun; 8(9):1337-44. PubMed ID: 17563267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finasteride in benign prostatic hyperplasia.
    Verhamme KM; Bosch RJ; Sturkenboom MC
    N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
    [No Abstract]   [Full Text] [Related]  

  • 18. Benign prostatic hyperplasia: pathophysiology and pharmacological treatment.
    Madsen FA; Bruskewitz RC
    Curr Opin Nephrol Hypertens; 1995 Sep; 4(5):455-9. PubMed ID: 8564452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Brawer MK; Dixon CM; Gormley G; Haakenson C; Machi M; Narayan P; Padley RJ
    N Engl J Med; 1996 Aug; 335(8):533-9. PubMed ID: 8684407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: an economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    Can J Urol; 2005 Feb; 12(1):2508-9; author reply 2509-10. PubMed ID: 15777487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.